What we're seeing
The AdvisorShares Pure US Cannabis ETF (MSOS) just posted its heaviest single-day turnover in eleven weeks — 4.1 million shares against a 20-day average near 1.3M. That's not a tape we usually associate with retail. The block-trade signature, the concentration above VWAP, and the call-heavy options skew all point to professional capital quietly stepping back into the sector.
Why this matters now
For most of 2024 and the first half of 2025, MSOS traded like a left-for-dead vehicle. Average daily dollar volume fell below $5M for stretches. When liquidity dries up that severely, institutional desks can't build a position without moving the tape against themselves. The recent jump in turnover changes that calculus.
The move comes against a backdrop of the 2026 Farm Bill markup, a softer-than-expected CPI print, and renewed chatter around DEA scheduling timelines. None of those are confirmed catalysts — but the tape is acting like someone is positioning for them.
What to watch
1. Sustained turnover above 2.5M shares/day — one print is a tell; a week is a trend
2. MSOS premium/discount to NAV — institutional flows usually compress the discount first
3. Top-five holdings (GTBIF, CURA, TCNNF, TRUL, VRNO) — if the ETF lifts but constituents lag, it's mechanical buying; if constituents lead, it's a real bid
Bottom line
We're not calling a bottom. We're calling a regime change in liquidity. That's a precondition for any sustained re-rating in MSOs — and it's the first one we've seen since the SAFE Banking optimism of late 2021.